
Dkleo Pharma Private Limited
Founded in 2020 and headquartered in Maharashtra, India.
Founded in 2020 and headquartered in Maharashtra, India.
Mumbai, Maharashtra, India
+91-XXXXXXXXXX
U24299MH2020FTC335759
335759
Private Limited Foreign Company Incorporated In India
09 Jan 2020
19 Jun 2023
31 Mar 2023
Unlisted
Roc Mumbai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kalambur Chandrasekaran ![]() | Director | 09-Jan-2020 | Current |
Jakob Gregersen ![]() | Director | 25-Jan-2024 | Current |
Enhance accessibility to Dkleo Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Dkleo Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Kalambur Chandrasekaran is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Dkleo Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Dkleo Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dkleo Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Jakob Gregersen was appointed as a Director was appointed as a Director on 25 Jan 2024 & has been associated with this company since 1 year 3 months .
Dkleo Pharma Private Limited last Annual general meeting of members was held on 19 Jun 2023 as per latest MCA records.
Dkleo Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
Kalambur Narasimhan Chandrasekaran was appointed as a Director was appointed as a Director on 09 Jan 2020 & has been associated with this company since 5 years 4 months .
Dkleo Pharma Private Limited was registered on 09 Jan 2020 with Roc Mumbai & aged 5 years 4 months as per MCA records.
Dkleo Pharma Private Limited was incorporated on 09 Jan 2020.
The authorized share capital of Dkleo Pharma Private Limited is ₹ 1.53 Cr and paid-up capital is ₹ 1.51 Cr.
Currently 2 directors are associated with Dkleo Pharma Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Dkleo Pharma Private Limited is Executive Centre B Wing Level 7 The Capital G- Block Bandra Kurla Complex, ( E) India, Mumbai, Maharashtra, 400051.
The corporate identification number (CIN) of Dkleo Pharma Private Limited is U24299MH2020FTC335759 and the company number is 335759 as per Ministry of Corporate Affairs (MCA).
The most recent Balance Sheet for Dkleo Pharma Private Limited was filed with the ROC on 31 Mar 2023.
Search company & director profiles for free and gain access to critical business data.
MG